{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T04:44:05Z","timestamp":1792039445921,"version":"4.4.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,12,22]],"date-time":"2016-12-22T00:00:00Z","timestamp":1482364800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,12,22]],"date-time":"2016-12-22T00:00:00Z","timestamp":1482364800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1038\/gt.2016.74","type":"journal-article","created":{"date-parts":[[2016,11,11]],"date-time":"2016-11-11T15:43:46Z","timestamp":1478879026000},"page":"40-48","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["The antitumor efficacy of anti-p21Ras scFv mediated by the dual-promoter-regulated recombinant adenovirus KGHV300"],"prefix":"10.1038","volume":"24","author":[{"given":"X Y","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X J","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S J","family":"Zhen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D X","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W X","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y L","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H W","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J L","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,12,22]]},"reference":[{"key":"BFgt201674_CR1","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1177\/1947601911411084","volume":"2","author":"A Fernandez-Medarde","year":"2011","unstructured":"Fernandez-Medarde A, Santos E . Ras in cancer and developmental diseases. Genes Cancer 2011; 2: 344\u2013358.","journal-title":"Genes Cancer"},{"key":"BFgt201674_CR2","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1093\/jnci\/93.14.1062","volume":"93","author":"AA Adjei","year":"2001","unstructured":"Adjei AA . Blocking oncogenic Ras signaling for cancer therapy. J Natl Cancer Inst 2001; 93: 1062\u20131074.","journal-title":"J Natl Cancer Inst"},{"key":"BFgt201674_CR3","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1006\/bbrc.1998.9527","volume":"251","author":"S Miyakis","year":"1998","unstructured":"Miyakis S, Sourvinos G, Spandidos DA . Differential expression and mutation of the ras family genes in human breast cancer. Biochem Biophys Res Commun 1998; 251: 609\u2013612.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFgt201674_CR4","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1309\/AJCP7FO2VAXIVSTP","volume":"135","author":"X Liu","year":"2011","unstructured":"Liu X, Jakubowski M, Hunt JL . KRAS gene mutation in colorectal cancer is correlated with increased proliferation and spontaneous apoptosis. Am J Clin Pathol 2011; 135: 245\u2013252.","journal-title":"Am J Clin Pathol"},{"key":"BFgt201674_CR5","first-page":"1444","volume":"55","author":"NE Mills","year":"1995","unstructured":"Mills NE, Fishman CL, Rom WN, Dubin N, Jacobson DR . Increased prevalence of K-ras oncogene mutations in lung adenocarcinoma. Cancer Res 1995; 55: 1444\u20131447.","journal-title":"Cancer Res"},{"key":"BFgt201674_CR6","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.radonc.2013.06.023","volume":"108","author":"M Saki","year":"2013","unstructured":"Saki M, Toulany M, Rodemann HP . Acquired resistance to cetuximab is associated with the overexpression of Ras family members and the loss of radiosensitization in head and neck cancer cells. Radiother Oncol 2013; 108: 473\u2013478.","journal-title":"Radiother Oncol"},{"key":"BFgt201674_CR7","first-page":"627","volume":"4","author":"S Hamdy","year":"1994","unstructured":"Hamdy S, Aprikian A, Begin L, Fair W, Bazinet M . Ras p21 overexpression is a late event in prostate-cancer. Int J Oncol 1994; 4: 627\u2013631.","journal-title":"Int J Oncol"},{"key":"BFgt201674_CR8","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1073\/pnas.82.6.1795","volume":"82","author":"GE Gallick","year":"1985","unstructured":"Gallick GE, Kurzrock R, Kloetzer WS, Arlinghaus RB, Gutterman JU . Expression of p21ras in fresh primary and metastatic human colorectal tumors. Proc Natl Acad Sci USA 1985; 82: 1795\u20131799.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFgt201674_CR9","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1097\/00043764-199604000-00017","volume":"38","author":"R Novara","year":"1996","unstructured":"Novara R, Coda R, Martone T, Vineis P . Exposure to aromatic amines and ras and c-erbB-2 overexpression in bladder cancer. J Occup Environ Med 1996; 38: 390\u2013393.","journal-title":"J Occup Environ Med"},{"key":"BFgt201674_CR10","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.celrep.2015.06.044","volume":"12","author":"ZY Zheng","year":"2015","unstructured":"Zheng ZY, Tian L, Bu W, Fan C, Gao X, Wang H et al. Wild-type N-Ras, overexpressed in basal-like breast cancer, promotes tumor formation by inducing IL-8 secretion via JAK2 activation. Cell Rep 2015; 12: 511\u2013524.","journal-title":"Cell Rep"},{"key":"BFgt201674_CR11","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12885-016-2168-6","volume":"16","author":"JL Yang","year":"2016","unstructured":"Yang JL, Liu DX, Zhen SJ, Zhou YG, Zhang DJ, Yang LY et al. A novel anti-p21Ras scFv antibody reacting specifically with human tumour cell lines and primary tumour tissues. BMC Cancer 2016; 16: 131.","journal-title":"BMC Cancer"},{"key":"BFgt201674_CR12","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.3892\/ijo.2016.3334","volume":"48","author":"JL Yang","year":"2016","unstructured":"Yang JL, Pan XY, Zhao WX, Hu QC, Ding F, Feng Q et al. The antitumor efficacy of a novel adenovirus-mediated anti-p21Ras single chain fragment variable antibody on human cancers in vitro and in vivo. Int J Oncol 2016; 48: 1218\u20131228.","journal-title":"Int J Oncol"},{"key":"BFgt201674_CR13","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1667\/0033-7587(2001)155[0188:TATIFC]2.0.CO;2","volume":"155","author":"JW Shay","year":"2001","unstructured":"Shay JW, Wright WE . Telomeres and telomerase: implications for cancer and aging. Radiat Res 2001; 155: 188\u2013193.","journal-title":"Radiat Res"},{"key":"BFgt201674_CR14","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1111\/j.1745-7254.2005.00098.x","volume":"26","author":"YH Hsu","year":"2005","unstructured":"Hsu YH, Lin JJ . Telomere and telomerase as targets for anti-cancer and regeneration therapies. Acta Pharmacol Sin 2005; 26: 513\u2013518.","journal-title":"Acta Pharmacol Sin"},{"key":"BFgt201674_CR15","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/6010","volume":"21","author":"KJ Wu","year":"1999","unstructured":"Wu KJ, Grandori C, Amacker M, Simon-Vermot N, Polack A, Lingner J et al. Direct activation of TERT transcription by c-MYC. Nat Genet 1999; 21: 220\u2013224.","journal-title":"Nat Genet"},{"key":"BFgt201674_CR16","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/S1359-6446(04)03202-7","volume":"9","author":"KS Hewitson","year":"2004","unstructured":"Hewitson KS, Schofield CJ . The HIF pathway as a therapeutic target. Drug Discov Today 2004; 9: 704\u2013711.","journal-title":"Drug Discov Today"},{"key":"BFgt201674_CR17","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/nrc1187","volume":"3","author":"GL Semenza","year":"2003","unstructured":"Semenza GL . Targeting HIF-1 for cancer therapy. Nat Rev Cancer 2003; 3: 721\u2013732.","journal-title":"Nat Rev Cancer"},{"key":"BFgt201674_CR18","doi-asserted-by":"publisher","first-page":"391","DOI":"10.2174\/1568009033481732","volume":"3","author":"SJ Welsh","year":"2003","unstructured":"Welsh SJ, Powis G . Hypoxia inducible factor as a cancer drug target. Curr Cancer Drug Targets 2003; 3: 391\u2013405.","journal-title":"Curr Cancer Drug Targets"},{"key":"BFgt201674_CR19","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1007\/s00894-011-1150-0","volume":"18","author":"P Sokkar","year":"2012","unstructured":"Sokkar P, Sathis V, Ramachandran M . Computational modeling on the recognition of the HRE motif by HIF-1: molecular docking and molecular dynamics studies. J Mol Model 2012; 18: 1691\u20131700.","journal-title":"J Mol Model"},{"key":"BFgt201674_CR20","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.bbamcr.2010.01.004","volume":"1803","author":"KJ Lee","year":"2010","unstructured":"Lee KJ, Lee KY, Lee YM . Downregulation of a tumor suppressor RECK by hypoxia through recruitment of HDAC1 and HIF-1alpha to reverse HRE site in the promoter. Biochim Biophys Acta 2010; 1803: 608\u2013616.","journal-title":"Biochim Biophys Acta"},{"key":"BFgt201674_CR21","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s00432-004-0577-4","volume":"130","author":"CQ Su","year":"2004","unstructured":"Su CQ, Sham J, Xue HB, Wang XH, Chua D, Cui ZF et al. Potent antitumoral efficacy of a novel replicative adenovirus CNHK300 targeting telomerase-positive cancer cells. J Cancer Res Clin Oncol 2004; 130: 591\u2013603.","journal-title":"J Cancer Res Clin Oncol"},{"key":"BFgt201674_CR22","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1089\/104303403766682205","volume":"14","author":"DE Post","year":"2003","unstructured":"Post DE, Khuri FR, Simons JW, Van Meir EG . Replicative oncolytic adenoviruses in multimodal cancer regimens. Hum Gene Ther 2003; 14: 933\u2013946.","journal-title":"Hum Gene Ther"},{"key":"BFgt201674_CR23","doi-asserted-by":"publisher","first-page":"8845","DOI":"10.1158\/1078-0432.CCR-05-1757","volume":"11","author":"Y Li","year":"2005","unstructured":"Li Y, Idamakanti N, Arroyo T, Thorne S, Reid T, Nichols S et al. Dual promoter-controlled oncolytic adenovirus CG5757 has strong tumor selectivity and significant antitumor efficacy in preclinical models. Clin Cancer Res 2005; 11: 8845\u20138855.","journal-title":"Clin Cancer Res"},{"key":"BFgt201674_CR24","doi-asserted-by":"publisher","first-page":"243","DOI":"10.2174\/1566524053586536","volume":"5","author":"T Wirth","year":"2005","unstructured":"Wirth T, Kuhnel F, Kubicka S . Telomerase-dependent gene therapy. Curr Mol Med 2005; 5: 243\u2013251.","journal-title":"Curr Mol Med"},{"key":"BFgt201674_CR25","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.ymthe.2004.07.023","volume":"10","author":"WK Cho","year":"2004","unstructured":"Cho WK, Seong YR, Lee YH, Kim MJ, Hwang KS, Yoo J et al. Oncolytic effects of adenovirus mutant capable of replicating in hypoxic and normoxic regions of solid tumor. Mol Ther 2004; 10: 938\u2013949.","journal-title":"Mol Ther"},{"key":"BFgt201674_CR26","doi-asserted-by":"publisher","first-page":"8603","DOI":"10.1158\/1078-0432.CCR-04-1432","volume":"10","author":"DE Post","year":"2004","unstructured":"Post DE, Devi NS, Li Z, Brat DJ, Kaur B, Nicholson A et al. Cancer therapy with a replicating oncolytic adenovirus targeting the hypoxic microenvironment of tumors. Clin Cancer Res 2004; 10: 8603\u20138612.","journal-title":"Clin Cancer Res"},{"key":"BFgt201674_CR27","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1158\/1535-7163.MCT-07-2429","volume":"7","author":"X Wang","year":"2008","unstructured":"Wang X, Su C, Cao H, Li K, Chen J, Jiang L et al. A novel triple-regulated oncolytic adenovirus carrying p53 gene exerts potent antitumor efficacy on common human solid cancers. Mol Cancer Ther 2008; 7: 1598\u20131603.","journal-title":"Mol Cancer Ther"},{"key":"BFgt201674_CR28","doi-asserted-by":"publisher","first-page":"R220","DOI":"10.1186\/bcr975","volume":"7","author":"YH Wang","year":"2005","unstructured":"Wang YH, Liu S, Zhang G, Zhou CQ, Zhu HX, Zhou XB et al. Knockdown of c-Myc expression by RNAi inhibits MCF-7 breast tumor cells growth in vitro and in vivo. Breast Cancer Res 2005; 7: R220\u2013R228.","journal-title":"Breast Cancer Res"},{"key":"BFgt201674_CR29","first-page":"2947","volume":"8","author":"Q Chen","year":"2016","unstructured":"Chen Q, Cui XX, Liang PF, Dou JX, Liu ZY, Sun WW . Immunotherapy with dendritic cells and cytokine-induced killer cells for MDA-MB-231 breast cancer stem cells in nude mice. Am J Transl Res 2016; 8: 2947\u20132955.","journal-title":"Am J Transl Res"},{"key":"BFgt201674_CR30","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1743-422X-7-45","volume":"7","author":"W Li","year":"2010","unstructured":"Li W, Miao X, Qi Z, Zeng W, Liang J, Liang Z . Hepatitis B virus X protein upregulates HSP90alpha expression via activation of c-Myc in human hepatocarcinoma cell line, HepG2. Virol J 2010; 7: 45.","journal-title":"Virol J"},{"key":"BFgt201674_CR31","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1038\/sj.bjc.6601338","volume":"89","author":"D Arango","year":"2003","unstructured":"Arango D, Mariadason JM, Wilson AJ, Yang W, Corner GA, Nicholas C et al. c-Myc overexpression sensitises colon cancer cells to camptothecin-induced apoptosis. Br J Cancer 2003; 89: 1757\u20131765.","journal-title":"Br J Cancer"},{"key":"BFgt201674_CR32","first-page":"311","volume":"5","author":"DG Kieback","year":"2008","unstructured":"Kieback DG . Adenovirus-mediated thymidine kinase gene therapy and coxsackie adenovirus receptor expression in ovarian cancer cells. Cancer Genom Proteom 2008; 5: 311\u2013318.","journal-title":"Cancer Genom Proteom"},{"key":"BFgt201674_CR33","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1126\/science.1174229","volume":"325","author":"J Yun","year":"2009","unstructured":"Yun J, Rago C, Cheong I, Pagliarini R, Angenendt P, Rajagopalan H et al. Glucose deprivation contributes to the development of KRAS pathway mutations in tumor cells. Science 2009; 325: 1555\u20131559.","journal-title":"Science"},{"key":"BFgt201674_CR34","doi-asserted-by":"publisher","first-page":"5963","DOI":"10.1093\/nar\/15.15.5963","volume":"15","author":"SC Kozma","year":"1987","unstructured":"Kozma SC, Bogaard ME, Buser K, Saurer SM, Bos JL, Groner B et al. The human c-Kirsten ras gene is activated by a novel mutation in codon 13 in the breast carcinoma cell line MDA-MB231. Nucleic Acids Res 1987; 15: 5963\u20135971.","journal-title":"Nucleic Acids Res"},{"key":"BFgt201674_CR35","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s10534-014-9813-9","volume":"28","author":"Shweta","year":"2015","unstructured":"Shweta, Mishra KP, Chanda S, Singh SB, Ganju L . A comparative immunological analysis of CoCl2 treated cells with in vitro hypoxic exposure. Biometals 2015; 28: 175\u2013185.","journal-title":"Biometals"},{"key":"BFgt201674_CR36","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s00424-009-0702-y","volume":"459","author":"K Shirato","year":"2009","unstructured":"Shirato K, Kizaki T, Sakurai T, Ogasawara JE, Ishibashi Y, Iijima T et al. Hypoxia-inducible factor-1alpha suppresses the expression of macrophage scavenger receptor 1. Pflugers Arch 2009; 459: 93\u2013103.","journal-title":"Pflugers Arch"},{"key":"BFgt201674_CR37","doi-asserted-by":"publisher","first-page":"e76605","DOI":"10.1371\/journal.pone.0076605","volume":"8","author":"M Yamanaka-Tatematsu","year":"2013","unstructured":"Yamanaka-Tatematsu M, Nakashima A, Fujita N, Shima T, Yoshimori T, Saito S . Autophagy induced by HIF1alpha overexpression supports trophoblast invasion by supplying cellular energy. PLoS One 2013; 8: e76605.","journal-title":"PLoS One"},{"key":"BFgt201674_CR38","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.canlet.2012.09.003","volume":"328","author":"X Dong","year":"2013","unstructured":"Dong X, Qu W, Ma S, Zhu Z, Zheng C, He A et al. Potent antitumoral effects of targeted promoter-driven oncolytic adenovirus armed with Dm-dNK for breast cancer in vitro and in vivo. Cancer Lett 2013; 328: 95\u2013103.","journal-title":"Cancer Lett"},{"key":"BFgt201674_CR39","doi-asserted-by":"publisher","first-page":"5744","DOI":"10.4049\/jimmunol.1402207","volume":"193","author":"AJ Brennan","year":"2014","unstructured":"Brennan AJ, House IG, Oliaro J, Ramsbottom KM, Hagn M, Yagita H et al. A method for detecting intracellular perforin in mouse lymphocytes. J Immunol 2014; 193: 5744\u20135750.","journal-title":"J Immunol"},{"key":"BFgt201674_CR40","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1248\/bpb.34.197","volume":"34","author":"H Gao","year":"2011","unstructured":"Gao H, Liu L, Qu ZY, Wei FX, Wang SQ, Chen G et al. Anti-adenovirus activities of shikonin, a component of Chinese herbal medicine in vitro. Biol Pharm Bull 2011; 34: 197\u2013202.","journal-title":"Biol Pharm Bull"},{"key":"BFgt201674_CR41","first-page":"2751","volume":"9","author":"HG Wang","year":"1994","unstructured":"Wang HG, Miyashita T, Takayama S, Sato T, Torigoe T, Krajewski S et al. Apoptosis regulation by interaction of Bcl-2 protein and Raf-1 kinase. Oncogene 1994; 9: 2751\u20132756.","journal-title":"Oncogene"},{"key":"BFgt201674_CR42","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/1756-9966-31-51","volume":"31","author":"W Zhu","year":"2012","unstructured":"Zhu W, Wei L, Zhang H, Chen J, Qin X . Oncolytic adenovirus armed with IL-24 inhibits the growth of breast cancer in vitro and in vivo. J Exp Clin Cancer Res 2012; 31: 51.","journal-title":"J Exp Clin Cancer Res"},{"key":"BFgt201674_CR43","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.canlet.2013.06.010","volume":"339","author":"J Guo","year":"2013","unstructured":"Guo J, Gao J, Li Z, Gong Y, Man X, Jin J et al. Adenovirus vector-mediated Gli1 siRNA induces growth inhibition and apoptosis in human pancreatic cancer with Smo-dependent or Smo-independent Hh pathway activation in vitro and in vivo. Cancer Lett 2013; 339: 185\u2013194.","journal-title":"Cancer Lett"},{"key":"BFgt201674_CR44","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.ymthe.2004.05.006","volume":"10","author":"H Uchida","year":"2004","unstructured":"Uchida H, Tanaka T, Sasaki K, Kato K, Dehari H, Ito Y et al. Adenovirus-mediated transfer of siRNA against survivin induced apoptosis and attenuated tumor cell growth in vitro and in vivo. Mol Ther 2004; 10: 162\u2013171.","journal-title":"Mol Ther"},{"key":"BFgt201674_CR45","doi-asserted-by":"publisher","first-page":"6523","DOI":"10.1158\/1078-0432.CCR-06-1491","volume":"12","author":"Q Zhang","year":"2006","unstructured":"Zhang Q, Chen G, Peng L, Wang X, Yang Y, Liu C et al. Increased safety with preserved antitumoral efficacy on hepatocellular carcinoma with dual-regulated oncolytic adenovirus. Clin Cancer Res 2006; 12: 6523\u20136531.","journal-title":"Clin Cancer Res"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/gt201674.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gt201674","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gt201674.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T13:18:02Z","timestamp":1648559882000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/gt201674"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,22]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["BFgt201674"],"URL":"https:\/\/doi.org\/10.1038\/gt.2016.74","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,22]]},"assertion":[{"value":"4 July 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}